,120 Aberrant expression of the m6A reader IGF2BP1 has been observed in various types of cancers, including gastric cancer (GC), lung cancer, non-small-cell lung cancer (NSCLC), and HCC, and contributes to sustained tumor cells' abnormal proliferation by regulating the expression of oncogenes including MYC, serum response factor (SRF), thymidine kinase 1 (TK1), ALKBH5, and LY6/PLAUR domain containing 1 (LYPD1).47 The gene discussed is IGF2BP1; the disease is non-small cell lung carcinoma.